Small Business

Aurobindo back in black with Rs 103 cr profit

Aurobindo Pharma, Hyderabad-based manufacturer of generic and active pharmaceutical ingredients reported a net profit of Rs 103.2 crore for the quarter ended September 30, 2009, as against a net loss of Rs 38.4 crore during the corresponding period last year. Revenues were up 24.42 per cent to Rs 882.64 crore as compared with Rs 709.4 crore last year. - Aurobindo gets nod to market 2 more products in S Africa - Bharat Biotech"s "INDIRAB" vaccine sales doubles - Aurobindo gets US FDA nod - Suven Life"s drug discovery achieves milestone - Aurobindo Pharma receives Swissmedic approval - Aurobindo Pharma receives Swissmedic approval for cefepime for injection The company made a forex gain of Rs 3.7 crore during the quarter as against a loss of Rs 85.3 crore last year. Formulations sales increased 39.4 per cent to Rs 445.2 crore during the period as compared with Rs 319.3 crore, managing director K Nithyananda Reddy said in a release. Aurobindo had three abbreviated new drug applications and 16 dossier filings during the quarter.

Add your comment:

Name:
Site address:	http://
Your message:
Enter today\\\\'s date, 2 digits (spam protection):